Global Antiparasitic Drugs Market to Exhibit Rapid Surge in Consumption in the COVID-19 Crisis

 


Antiparasitic drugs, such as anthelmintics, antiporozoals and some other agents, are used in the treatment of parasitic infectious diseases. According to WHO reports, 1.5 billion people worldwide are affected by parasitic disease in March 2020. These diseases include gastrointestinal disorders, anaemia, waste and cognitive and development delays in children and other infections. Of the 1.5 billion people affected by parasitic infectious diseases, 24 per cent of people worldwide are infected with soil-borne helminth infections. Some parasitic infections are life-threatening, whereas others cause discomfort in a healthy lifestyle. 

The global demand for the antiparasitic drugs market was estimated at US$7,227.9 million in 2019 and is projected to have a CAGR of 5.2 per cent over the forecast years (2020–2027).

Global Antiparasitic Drugs Market- Regional Analysis

On a geographic basis, the global demand for antiparasitic drugs market is segemented into North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. 

Africa is projected to hold a dominant market place among regions due to a growing risk of malaria in the region. For example, according to the WHO, about 92% of malaria cases worldwide occur in sub-Saharan Africa. In 2017, the WHO also reported that of the five countries that accounted for almost half of all malaria cases globally, four countries came from Africa, including Nigeria (25%), the Democratic Republic of Congo (11 percent), Mozambique (5 percent) and Uganda (4 percent ).

For More Information, Click Here: https://www.globenewswire.com/news-release/2020/04/24/2021803/0/en/Global-Antiparasitic-Drugs-market-to-surpass-US-10-842-7-million-by-2027-Says-CMI.html

Comments

Post a Comment

Popular posts from this blog

Global Biofeedback Measurement Instrument Market to Rise During the COVID-19 Crisis Period Owing to Increasing Consumer Awareness

Image
  Increasing cases of neurological disorders, including depression, anxiety, ADHD, and other dementias, are expected to fuel the market growth of the biofeedback instrument market during the forecast period. For example, according to the World Alzheimer's Study released by Alzheimer's Disease International (ADI), new cases of dementia across regions in 2015 were 4.9 million (49.0 percent) in Asia Pacific, 2.5 million (25.0 percent) in Europe, 1.7 million (18.0 percent) in the Americas and 0.8 million (8.0 per cent) in Africa. In addition, according to Parkinson's UK, about 137,000 people in the UK suffered from Parkinson's disease in 2015. Parkinson's disease is the second most common age-related neurodegenerative condition after Alzheimer's. For example, according to Parkinson's UK, the estimated number of people with Parkinson's disease in Northern Ireland in 2015 was 241, 157 of whom were male and 85 were female. The global biofeedback instrument mark...
Read more

Global Pro AV Market from Key End-use Sectors to Surge in the Near Future

 Overview of the market  Pro AV refers to the sophisticated integration of audio-video devices used for commercial purposes. Pro AV uses multiple aspects such as display components, cameras, audio components, monitors, controls, space planners, whiteboard companions, advanced features such as digital signage, and other supporting accessories. Both of these components help to enhance connectivity and coordination between offices in two separate locations. It is therefore used in a number of industries, including education, government, hospitality/retail, and others.  The global Pro AV market was estimated at US$ 246.5 billion in 2019 and is projected to have a CAGR of 11.2 per cent during the forecast years (2020-2027).  Market Trend The integration of telecommunications applications including such Skype is a big trend in the global Pro AV industry.  The main players on the market are the integration of Pro AV products with telecommunications applications such as...
Read more

High Incidence of Ragweed Allergy and Emergence of Covid-19 to Augment Growth of Ragweed Pollen Allergy Treatment Market

Image
  Ragweed pollen is one of the most common causes of seasonal allergies in various countries. Symptoms of ragweed pollen allergy include, runny nose or congestion, coughing or wheezing, sinus pressure, itchy, watery eyes, scratchy throat, and swollen, bluish-colored skin beneath the eyes. Market Dynamics High incidence of ragweed allergy is expected to propel growth of the global ragweedpollen allergy treatment market . For instance, according to Asthma and Allergy Foundation of America, ragweed allergy affects 10 to 20% of people in the U.S. Moreover, high prevalence of asthma is also expected to aid in growth of the market. For instance, according to The Global Asthma Report 2018, the prevalence of asthma symptoms was 23% and the prevalence of a medical diagnosis of asthma 12% in Brazil. Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global ragweed pollen allergy treatment market. For instance, globally, as of 5:10pm CET, 9 Fe...
Read more